Matches in SemOpenAlex for { <https://semopenalex.org/work/W4297963313> ?p ?o ?g. }
Showing items 1 to 71 of
71
with 100 items per page.
- W4297963313 endingPage "e116" @default.
- W4297963313 startingPage "e112" @default.
- W4297963313 abstract "Abstract Anti-N-methyl-d-aspartate receptor (NMDAR) encephalitis has a very good outcome; however, there are few reports in developing countries regarding the outcome of pediatric anti-NMDAR encephalitis. We aimed to report the clinical outcome of pediatric anti-NMDAR encephalitis in the rural area of Thailand. This retrospective cohort study recruited children between the age of 1 month and 15 years with the diagnosis of anti-NMDAR encephalitis admitted at Maharat Nakhon Ratchasima Hospital from 1st May 2015 to 31th March 2020. Baseline characteristics and investigation were recorded. The first-line treatment was intravenous pulse methylprednisolone alone, pulse methylprednisolone plus intravenous immune globulin (IVIG), or IVIG alone. The second-line treatment was monthly intravenous cyclophosphamide or azathioprine. The modified Rankin Scale (MRS) was used for evaluation at 1, 3, 6, 12, 18, and 24 months after receiving first-line treatment to determine clinical outcomes. The factors that may affect the outcomes were evaluated. In total, 17 patients were recruited, with the mean age of 8 years, and 76.46% were female. 82.35% of patients developed seizures, and 52.94% turned to status epilepticus. 70.59% received first-line treatment as pulse methylprednisolone plus IVIG. 82.35% received complete follow-up at 12 months. According to MRS score, at first diagnosis 94.12% reported severe disability, at 1 month after receiving treatment, 47.06% improved to moderate–mild disability, and at 6 and 12 months, 40% and 78.57% had complete recovery, respectively. Different types of first-line and second-line treatments did not affect the clinical outcome. Comorbidity of status epilepticus affected MRS. Anti-NMDAR encephalitis has a very good prognosis; prompt diagnosis is necessary. Comorbidity as status epilepticus may affect the clinical outcome." @default.
- W4297963313 created "2022-10-01" @default.
- W4297963313 creator A5050830412 @default.
- W4297963313 creator A5075015967 @default.
- W4297963313 date "2022-01-01" @default.
- W4297963313 modified "2023-10-14" @default.
- W4297963313 title "Outcome of Pediatric Anti-N-Methyl-D-Aspartate (NMDA) Receptor Encephalitis in Rural Area of Thailand" @default.
- W4297963313 cites W2051552021 @default.
- W4297963313 cites W2087363103 @default.
- W4297963313 cites W2114398221 @default.
- W4297963313 cites W2146199022 @default.
- W4297963313 cites W2163022996 @default.
- W4297963313 cites W2280783985 @default.
- W4297963313 cites W2575795500 @default.
- W4297963313 cites W2898539043 @default.
- W4297963313 cites W2899243098 @default.
- W4297963313 cites W2911063497 @default.
- W4297963313 cites W2980350220 @default.
- W4297963313 cites W2983231102 @default.
- W4297963313 doi "https://doi.org/10.1055/s-0042-1757144" @default.
- W4297963313 hasPublicationYear "2022" @default.
- W4297963313 type Work @default.
- W4297963313 citedByCount "0" @default.
- W4297963313 crossrefType "journal-article" @default.
- W4297963313 hasAuthorship W4297963313A5050830412 @default.
- W4297963313 hasAuthorship W4297963313A5075015967 @default.
- W4297963313 hasBestOaLocation W42979633131 @default.
- W4297963313 hasConcept C126322002 @default.
- W4297963313 hasConcept C187212893 @default.
- W4297963313 hasConcept C203014093 @default.
- W4297963313 hasConcept C2522874641 @default.
- W4297963313 hasConcept C2780211071 @default.
- W4297963313 hasConcept C2780372218 @default.
- W4297963313 hasConcept C2780931571 @default.
- W4297963313 hasConcept C3020199598 @default.
- W4297963313 hasConcept C42219234 @default.
- W4297963313 hasConcept C541997718 @default.
- W4297963313 hasConcept C71924100 @default.
- W4297963313 hasConcept C83455156 @default.
- W4297963313 hasConceptScore W4297963313C126322002 @default.
- W4297963313 hasConceptScore W4297963313C187212893 @default.
- W4297963313 hasConceptScore W4297963313C203014093 @default.
- W4297963313 hasConceptScore W4297963313C2522874641 @default.
- W4297963313 hasConceptScore W4297963313C2780211071 @default.
- W4297963313 hasConceptScore W4297963313C2780372218 @default.
- W4297963313 hasConceptScore W4297963313C2780931571 @default.
- W4297963313 hasConceptScore W4297963313C3020199598 @default.
- W4297963313 hasConceptScore W4297963313C42219234 @default.
- W4297963313 hasConceptScore W4297963313C541997718 @default.
- W4297963313 hasConceptScore W4297963313C71924100 @default.
- W4297963313 hasConceptScore W4297963313C83455156 @default.
- W4297963313 hasIssue "01" @default.
- W4297963313 hasLocation W42979633131 @default.
- W4297963313 hasOpenAccess W4297963313 @default.
- W4297963313 hasPrimaryLocation W42979633131 @default.
- W4297963313 hasRelatedWork W1988612394 @default.
- W4297963313 hasRelatedWork W2070162113 @default.
- W4297963313 hasRelatedWork W2096691306 @default.
- W4297963313 hasRelatedWork W2780798786 @default.
- W4297963313 hasRelatedWork W2899243098 @default.
- W4297963313 hasRelatedWork W3092368702 @default.
- W4297963313 hasRelatedWork W3137826903 @default.
- W4297963313 hasRelatedWork W3185022302 @default.
- W4297963313 hasRelatedWork W4285528904 @default.
- W4297963313 hasRelatedWork W4385565478 @default.
- W4297963313 hasVolume "12" @default.
- W4297963313 isParatext "false" @default.
- W4297963313 isRetracted "false" @default.
- W4297963313 workType "article" @default.